Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Formula: C42H45ClN6O5S2
is a highly potent and orally bioavailable PI3K/mTOR dual inhibitor developed through structure-based drug design
PMID: 31329101
Apoptosis Activator 2 promotes the cytochrome c-dependent oligomerization of Apaf-1 into the mature apoptosome
InChiKey: VXNYQUQHOUERTR-UHFFFAOYSA-N
Rifaximin Size:Solid 10 mg Formula: C42H45ClN6O5S2Rifaximin is a semisynthetic antibiotic based on rifamycin. It has poor oral bioavailability, meaning that very little of the drug will be absorbed into the blood stream when it is taken orally. Rifaximin is used in the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy, for which it received orphan drug status from the U. S. Food and Drug Administration in 1998. Rifaximin interferes with transcription by binding to